Allogeneic stem cell transplantation for the treatment of advanced solid tumors

Springer Seminars in Immunopathology
Marco BregniJacopo Peccatori

Abstract

Allogeneic stem cell transplantation has emerged as a potentially curative treatment modality for patients with hematological malignancies. The graft-versus-leukemia effect, an immune mechanism mediated by the donor immune system, is an important component of the therapeutic effect of allogeneic transplantation. Recent data from experimental animal models and from preliminary clinical experience suggest that a graft-versus-tumor effect, analogous to the graft-versus-leukemia effect, may be generated against solid tumors such as renal cell cancer, breast cancer, and other malignancies. The use of non-myeloablative, immunosuppressive conditioning regimens offers the opportunity to achieve a full-donor engraftment with reduced transplant-related complications and mortality, enabling also patients of advanced age and with co-morbidities to receive an allografting. Advanced renal cell cancer, an essentially incurable disease, has emerged from pilot studies as a disease susceptible to the graft-versus-tumor effect. Future studies will demonstrate if the tumor responses observed after allografting will translate into a clinically meaningful survival advantage. Other tumors in which tumor responses have been observed are: breast cancer...Continue Reading

References

May 10, 1979·The New England Journal of Medicine·P L WeidenR Storb
Jun 18, 1981·The New England Journal of Medicine·P L WeidenUNKNOWN Seattle Marrow Transplant Team
Mar 24, 1994·The New England Journal of Medicine·J O Armitage
Jan 1, 1994·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J O Armitage
Jul 7, 1993·JAMA : the Journal of the American Medical Association·O RingdénM M Bortin
Feb 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R H CollinsJ Nemunaitis
Mar 28, 1997·International Journal of Cancer. Journal International Du Cancer·S MoreckiS Slavin
Jan 1, 1997·Immunologic Research·Y Kawakami, S A Rosenberg
Mar 21, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N T UenoR E Champlin
Dec 14, 1999·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·E D Thomas, K G Blume
Mar 29, 2000·Bone Marrow Transplantation·J O BayD Blaise
Nov 25, 2000·British Journal of Haematology·J Barrett, R Childs
Apr 24, 2001·Cancer Immunology, Immunotherapy : CII·N RenkvistG Parmiani
May 18, 2001·Nature·F R Appelbaum
Apr 17, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Brian I RiniNicholas J Vogelzang
May 10, 2002·International Journal of Hematology·Frederick R Appelbaum
Mar 26, 2003·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·David A RizzieriNelson J Chao

❮ Previous
Next ❯

Citations

Feb 6, 2009·Journal of Pediatric Hematology/oncology·Christian M CapitiniTerry J Fry
Oct 9, 2007·Experimental Hematology·Margot ZöllerThomas Luft
Dec 3, 2008·International Journal of Cancer. Journal International Du Cancer·Xiaosan SuShuren Zhang
Jan 6, 2010·International Journal of Cancer. Journal International Du Cancer·Jacques-Olivier BayMarco Bregni
Nov 11, 2010·Transplant International : Official Journal of the European Society for Organ Transplantation·Jinpu YuXishan Hao
Sep 27, 2005·Transplantation Proceedings·F Carnevale-SchiancaM Aglietta
Oct 24, 2013·British Journal of Cancer·U ThielUNKNOWN Solid Tumour Working Party and the Paediatric Disease Working Party of the European Group for Blood and Marrow Transplantati
Sep 3, 2016·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Zhiwei ZhangXin Song

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.